Showing results (141-150 of 4,999) with videos related to
Sort By:
Pageof 500
Journal of Bacteriology|May 1, 1993
Proteolytic processing of the protease which initiates degradation of small, acid-soluble proteins during germination of Bacillus subtilis sporesJ L Sanchez-Salas, P SetlowAntimicrobial Agents and Chemotherapy|June 1, 1982
Effect of method of administration on extravascular penetration of four antibioticsL L Van Etta, G R Kravitz, T E Russ, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 17, 2009
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysisJ Price, E Cheek, S Lippett, et al.Revista De Neurologia|February 23, 2011
[A review of the construct of mild cognitive impairment: general aspects]J L Sanchez-Rodriguez, C Torrellas-MoralesChemotherapy|January 1, 1994
Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureusL R Peterson, I Cooper, K E Willard, et al.Journal of Clinical Microbiology|August 1, 1994
Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strainsM Kristjánsson, M H Samore, D N Gerding, et al.Lancet (London, England)|November 5, 1983
Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitisD G Teasley, D N Gerding, M M Olson, et al.Archives of Internal Medicine|January 1, 1986
Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic studyD N Gerding, M M Olson, L R Peterson, et al.The American Journal of Dermatopathology|January 1, 1984
Behavior of melanocytic nevi during pregnancyJ L Sanchez, L D Figueroa, E RodriguezAnaerobe|September 17, 2009
Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infectionD M Citron, F Babakhani, E J C Goldstein, et al.Pageof 500